Annual report
Page 1
SEDANAMEDICAL Pioneering volatile anaesthetic delivery Interest in inhaled sedation increased significantly during the year Submitted application for marketing authorisation in Europe The pivotal Sedaconda study reached its primary endpoint Well on the way to the vision of making inhaled sedation a global standard therapy ANNUAL REPORT 2020